• Singles™ is a breakthrough development enabling efficient culturing of human stem cells as single-cells in suspension. The cells grown using the Singles™ technology are uniform, undifferentiated, self-renewable, and form single or duplicate cells in suspension.
     
    • Concentration: >40 million cells/ml
    • Expansion factor: X50-100 fold in 7 days
    • Suitable for human pluripotent stem cells and progenitor cells
    • Better control of induced differentiation in suspension
    • Platform for genetic modification
    • High cloning efficiency
    • High recovery rates from freeze-thaw cycles
    • Does not require enzymatic splitting
    • Rock inhibitor-free, xeno-free defined medium